Lv7
4820 积分 2021-10-25 加入
Prognostic risk factors and a survival prediction model for immune checkpoint inhibitor related myocarditis in patients with lung cancer: a multicenter study
1天前
待确认
Reply
1天前
已完结
Immune checkpoint inhibitor–associated myocarditis: Incidence, risk factors, and clinical outcomes in a global real-world cohort
1天前
已完结
Overlapping Syndrome of Myocarditis, Myositis, Transaminitis, and Myasthenia Gravis in a Patient with Hepatocellular Carcinoma after Treatment with Immune Checkpoint Inhibitors: A Case Report and Literature Review
1天前
求助中
Relationship between Podocyte Injury and Renal Outcomes in Patients with Acute Kidney Injury: A Report from a Retrospective Study in China
1天前
已完结
Highly suspected fulminant myocarditis induced by the immune checkpoint inhibitor tislelizumab: a case report with third-degree atrioventricular block and recurrent ventricular tachycardia
1天前
已完结
Pathological mechanisms and treatment strategies for immune checkpoint inhibitor-associated myocarditis: insights from single-cell sequencing
1天前
已完结
A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers
1天前
待确认
2025 ESC Guidelines for the management of myocarditis and pericarditis
1天前
已完结
How should immune checkpoint inhibitor myocarditis be treated?
1天前
待确认
皖公网安备34019202002308
